Unknown

Dataset Information

0

MRNA vaccine development for cholangiocarcinoma: a precise pipeline


ABSTRACT: Cholangiocarcinoma (CHOL) is one of the most aggressive tumors worldwide and cannot be effectively treated by conventional and novel treatments, including immune checkpoint blockade therapy. The mRNA vaccine-based immunotherapeutic strategy has attracted much attention for various diseases, however, its application in CHOL is limited due to the thoughtlessness in the integration of vaccine design and patient selection. A recent study established an integrated path for identifying potent CHOL antigens for mRNA vaccine development and a precise stratification for identifying CHOL patients who can benefit from the mRNA vaccines. In spite of a promising prospect, further investigations should identify immunogenic antigens and onco-immunological characteristics of CHOL to guide the clinical application of CHOL mRNA vaccines in the future.

SUBMITTER: Tang T 

PROVIDER: S-EPMC9277828 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6892263 | biostudies-literature
| 35283 | ecrin-mdr-crc
| S-EPMC9863218 | biostudies-literature
| S-EPMC7911542 | biostudies-literature
| S-EPMC10384963 | biostudies-literature
| S-EPMC6289140 | biostudies-literature
| S-EPMC10071941 | biostudies-literature
| S-EPMC5159203 | biostudies-other
| S-EPMC7685956 | biostudies-literature
| S-EPMC10492027 | biostudies-literature